EUVIMEDEUVIMED entdecken
Crossref

Platelet dropping, bleeding and new treatment requirements in ITP patients after inactivated COVID-19 vaccination

Xiao-Yong Zhan, Hui Chen, Huimin Kong, Tongfei Meng, Jieyu Ye, Yong Liu, Margaret H L Ng, Liang Li, Yuming Zhang, Jinqi Huang, Qiang Peng, Chun Chen und 2 weitere

Immunology Letters · 2023

DOI: 10.1016/j.imlet.2023.11.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology Letters, 2023. Verfasst von Xiao-Yong Zhan und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Significant decreases in platelet counts and ITP relapses have been documented in ITP patients receiving COVID-19 mRNA vaccines; however, the effect of the inactivated COVID-19 vaccine on ITP patients remains unclear. The present study aimed to investigate the impact of inactivated COVID-19 vaccines on ITP patients, with a focus on platelet dropping events, bleeding events/scores, and the requirement of a new round of treatment. A total of 118 ITP patients, with 97 chronic ITP and 21 persistent ITP, who received inactivated COVID-19 immunization were investigated retrospectively. Following vaccination (within 1 month), ITP patients reported platelet dropping (31.36 %), new bleeding events (22.88 %), increases in bleeding scores (23.73 %), and new treatment requirements (22.03 %). Among them, persistent ITP patients with disease duration of 3-12 months had higher ratios of the above adverse events (71.43 %, 57.14 %, 61.90 % and 71.43 %, respectively) than chronic ITP patients with duration > 1 year (22.68 %, 15.46 %, 15.46 % and 11.34 %, respectively); patients' disease duration was negatively correlated with platelet dropping events and new treatment requirements. Furthermore, logistic regression analysis also supported the above findings, revealing that persistent ITP patients had 9.40-9.70, 7.24-10.08, and 27.17-28.51 times incidence of having platelet dropping events, new bleeding events, and new treatment requirements after vaccination, respectively, when compared to chronic ITP patients. In conclusion, the present study demonstrates that after receiving inactivated COVID-19 vaccines, ITP patients may experience platelet dropping, which may lead to new bleeding events and the requirement of a new round of treatment for ITP recurrence. As a result, platelet level monitoring is crucial for ITP patients during the vaccination, especially those with persistent ITP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesPurpura, Thrombocytopenic, IdiopathicHumansChronic DiseaseHemorrhageRetrospective StudiesVaccination

Stichwörter der Autor:innen

Adverse eventsCOVID-19Disease durationImmune thrombocytopeniaInactivated vaccine

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
  • The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. Electronic address: chenh576@mail.sysu.edu.cn.
  • ITP Home, Beijing, China.
  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China.
  • Department of Hematology, Hematology Research Institute, Affiliated Hospital of Guangdong Medical University (GDMU), Zhanjiang, China.

Förderung

  • National Natural Science Foundation of China
  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Zhan, X. Y., Chen, H., Kong, H., Meng, T., Ye, J., Liu, Y., Ng, M. H. L., Li, L., Zhang, Y., Huang, J., Peng, Q., Chen, C., He, Y., & Yang, M. (2023). Platelet dropping, bleeding and new treatment requirements in ITP patients after inactivated COVID-19 vaccination. Immunology Letters. https://doi.org/10.1016/j.imlet.2023.11.007

Vancouver

Zhan XY, Chen H, Kong H, Meng T, Ye J, Liu Y, et al. Platelet dropping, bleeding and new treatment requirements in ITP patients after inactivated COVID-19 vaccination. Immunology Letters. 2023. doi:10.1016/j.imlet.2023.11.007

BibTeX
@article{Zhan2023,
  author = {Zhan, Xiao-Yong and Chen, Hui and Kong, Huimin and Meng, Tongfei and Ye, Jieyu and Liu, Yong and Ng, Margaret H L and Li, Liang and Zhang, Yuming and Huang, Jinqi and Peng, Qiang and Chen, Chun and He, Yulong and Yang, Mo},
  title = {Platelet dropping, bleeding and new treatment requirements in ITP patients after inactivated COVID-19 vaccination},
  journal = {Immunology Letters},
  year = {2023},
  doi = {10.1016/j.imlet.2023.11.007}
}
Kostenlos starten →